- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Role of Genetic vs Genomic Testing in Cancer
“When I think about genetic testing, I think about screening,” says David C. Collymore, MD, MBA. In his opinion, genetic testing finds application in “screening large populations of people to see who is susceptible to certain illnesses.”
Genomic testing, on the other hand, has application following diagnosis, according to Dr Collymore. “When an illness has been identified, what treatment can be tailored to improve the outcomes of that individual? One is a screening mindset and the other a treatment mindset,” Dr Collymore explained.
It is necessary, though, to consider the cost-to-benefit ratio for these tests, he advised. “With any screening modality, you want to ensure that the cost of the screening mechanism, over a broader population, makes it an effective [to detect] illnesses in that broader population,” said Dr Collymore.
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis
April 23rd 2025Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.
Read More
